ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) (www.biomoda.com) will present the latest developments on its CyPath® diagnostic assay for the detection of early-stage lung cancer at the LifeTech Capital Miami Medical Investors Conference on Friday, November 12, 2010, in Miami, Florida.
